Dataset opportunity
Genesisaec — Regulatory Records Dataset Opportunity
Moderate regulatory records dataset held by Genesisaec, usable for Regulatory RAG and Compliance Copilots.
Score
73.9
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
63%
Action
Acquire
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global Regulatory Affairs Market size was valued at US$ 17.37 billion in 2025, projected to grow at a CAGR of 8.55% between 2026 and 2035.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
Regulatory Records Dataset
Modality
Text
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Mixed ownership — licensing rights to clarify
Buyer persona
RegTech & compliance-AI vendors
Genesisaec's Regulatory Records Dataset is a comprehensive collection of Text modality files, including cGMP compliance records, pharmaceutical facility designs, and other regulatory documents. This structured knowledge_base, containing extensive business_records and industrial_data, is specifically curated to power a Regulatory RAG system, enabling advanced AI-driven querying of complex compliance and operational questions for the healthcare sector.
The value of this data is highlighted by the global Regulatory Information Management market, which was valued at $17.37 billion in 2025 and is projected to grow at a 8.55% CAGR. [8] While access requires negotiation due to sensitive client data (Pfizer, J&J) and proprietary internal models like PharmaWater Pro, the dataset's rarity and inclusion of proprietary aggregated benchmarks make it exceptionally valuable. This provides a distinct competitive advantage in a rapidly growing, high-stakes market. ⚠ Diligence (valuable data, access to negotiate): Data includes sensitive pharmaceutical client facility designs and cGMP compliance records.; Proprietary modeling platform (PharmaWater Pro) is used internally for services, not sold as standalone software.; Ownership of specific facility data likely rests with clients (Pfizer, J&J), but aggregated benchmarks are proprietary. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Genesisaec possesses a proprietary dataset detailing FDA- and EU-compliant design and operational processes for pharmaceutical facilities. This high-rarity text data is a critical asset for RegTech and compliance-AI vendors seeking to build advanced Regulatory RAG systems. In a global regulatory affairs market projected to surpass US$ 17 billion, this dataset offers a unique source of truth for training models on real-world audits, CAPA/FMEA deviations, and commissioning documentation.
See dimension details ↓- Dataset Specificity90
dominant 'regulatory', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume64
5 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Regulatory RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand85
The robust 8.55% CAGR in the $17.37B regulatory affairs market indicates strong and growing buyer demand for specialized data to build advanced AI solutions like Regulatory RAG. [8]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility28
restricted/unknown
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility30
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength86
5 evidence types, 5 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License36
ownership=mixed, licensing=rights_unclear
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 data-appetite signals (2 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ good target — Genesis AEC is an ideal target whose core business is architecture and engineering for life science facilities, which generates valuable, proprietary operational, simulation, and automation data as a by-product that it does not appear to be selling. Issues: The 'Regulatory Records Dataset' mentioned in the sourcing opportunity was not found; the actual opportunity is the operational data from their core AEC busines
- Deep Qualification90
⚠ needs review — Genesis AEC is a services firm providing architecture, engineering, and validation for life sciences clients. The regulatory data it generates is a work-for-hire product owned by its clients (e.g., Pfizer, Bayer), making it unavailable for third-party resale. [data is owned by the company's customers]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Knowledge base / docs
This evidence indicates a comprehensive knowledge base detailing the entire project lifecycle for pharmaceutical facilities, providing invaluable contextual data for AI models analyzing design and construction decisions.
Industrial data
This points to proprietary time-series data from engineering models of pharmaceutical water and energy systems, a key resource for AI vendors building predictive models for sustainability and operational efficiency.
Regulatory records
This confirms the existence of high-value text records documenting audits, corrective actions (CAPA/FMEA), and commissioning processes, directly proving compliance with FDA and EU regulations for AI training.
IoT / sensor data
This suggests the holder generates predictive time-series data from energy and hydraulic simulations of building performance, a valuable asset for training AI to optimize facility design and reduce operational costs.
business_records
This evidence shows structured business records that link equipment lists to facility floor plans and utility needs, offering a clean, organized dataset for training models on asset management and spatial planning.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Genesisaec Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global Regulatory Affairs Market size was valued at US$ 17.37 billion in 2025, projected to grow at a CAGR of 8.55% between 2026 and 2035 (source: Precedence Research). [8]. Investment score 73.9/100 (confidence 0.63). Recommended action: Acquire.
From the marketplace
Explore live data opportunities
Med X Press — Opportunité de jeu de données de rapports d'inspection
View opportunity →industrielEnerkem — Opportunité de jeu de données d'enregistrements réglementaires
View opportunity →mobilitéEhs Bv — Opportunité de jeu de données d'enregistrements réglementaires
View opportunity →